Tracking clonal evolution of drug resistance in ovarian cancer patients by exploiting structural variants in cfDNA

Williams MJ, Vázquez-García I, Tam G, Wu M, Varice N, Havasov E, Shi H, Satas G, Lees HJ, Lee JJ, Myers MA, Zatzman M, Rusk N, Ali E, Shah RH, Berger MF, Mohibullah N, Lakhman Y, Chi DS, Abu-Rustum NR, Aghajanian C, McPherson A, Zamarin D, Loomis B, Weigelt B, Friedman CF, Shah SP.

Open source

DOI: 10.1101/2024.08.21.609031
Published: 2024-08-23
Container: Not recorded
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 41/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
cautionPublication version: Identified as a preprint; peer review and later versions may change the record. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1101/2024.08.21.609031,
  title = {Tracking clonal evolution of drug resistance in ovarian cancer patients by exploiting structural variants in cfDNA},
  author = {Williams MJ and  Vázquez-García I and  Tam G and  Wu M and  Varice N and  Havasov E and  Shi H and  Satas G and  Lees HJ and  Lee JJ and  Myers MA and  Zatzman M and  Rusk N and  Ali E and  Shah RH and  Berger MF and  Mohibullah N and  Lakhman Y and  Chi DS and  Abu-Rustum NR and  Aghajanian C and  McPherson A and  Zamarin D and  Loomis B and  Weigelt B and  Friedman CF and  Shah SP.},
  year = {2024},
  doi = {10.1101/2024.08.21.609031},
  url = {https://doi.org/10.1101/2024.08.21.609031}
}

RIS

TY  - JOUR
TI  - Tracking clonal evolution of drug resistance in ovarian cancer patients by exploiting structural variants in cfDNA
AU  - Williams MJ
AU  -  Vázquez-García I
AU  -  Tam G
AU  -  Wu M
AU  -  Varice N
AU  -  Havasov E
AU  -  Shi H
AU  -  Satas G
AU  -  Lees HJ
AU  -  Lee JJ
AU  -  Myers MA
AU  -  Zatzman M
AU  -  Rusk N
AU  -  Ali E
AU  -  Shah RH
AU  -  Berger MF
AU  -  Mohibullah N
AU  -  Lakhman Y
AU  -  Chi DS
AU  -  Abu-Rustum NR
AU  -  Aghajanian C
AU  -  McPherson A
AU  -  Zamarin D
AU  -  Loomis B
AU  -  Weigelt B
AU  -  Friedman CF
AU  -  Shah SP.
PY  - 2024
DO  - 10.1101/2024.08.21.609031
UR  - https://doi.org/10.1101/2024.08.21.609031
ER  -

APA

MJ, W., I, V., G, T., M, W., N, V., E, H., H, S., G, S., HJ, L., JJ, L., MA, M., M, Z., N, R., E, A., RH, S., MF, B., N, M., Y, L., DS, C., NR, A., C, A., A, M., D, Z., B, L., B, W., CF, F., & SP., S. (2024). Tracking clonal evolution of drug resistance in ovarian cancer patients by exploiting structural variants in cfDNA. https://doi.org/10.1101/2024.08.21.609031

Source records

europe-pmc · retrieved 2026-09-27T12:22:32.549Z